Sailer Carl 4
4 · Acurx Pharmaceuticals, Inc. · Filed Apr 22, 2026
Research Summary
AI-generated summary of this filing
Acurx (ACXP) Director Carl Sailer Receives Stock Option Award
What Happened Carl Sailer, a director of Acurx Pharmaceuticals (ACXP), was granted a stock option award for 2,150 shares on April 20, 2026. The award is recorded as a derivative grant (transaction code A) at an acquisition price of $0.00 (i.e., an option/award rather than a cash purchase). The filing was made on April 22, 2026.
Key Details
- Transaction date: 2026-04-20; Form 4 filed: 2026-04-22 (appears timely).
- Grant: 2,150 shares (stock option award); reported price: $0.00 (derivative).
- Shares owned after transaction: not specified in the public Form 4 filing.
- Footnote: Award granted under the Issuer’s Director Compensation Policy; the options vest on April 20, 2027.
- Transaction type: Award/Grant (A) — not an exercise or sale.
Context This is a routine director compensation grant rather than a market purchase or sale. The options are subject to one-year vesting and do not indicate immediate cash realized or a change in ownership today. Such grants are common for board service and should be viewed as compensation, not an urgent bullish or bearish signal.
Insider Transaction Report
- Award
Stock Option
[F1]2026-04-20+2,150→ 2,150 totalExercise: $2.36From: 2027-04-20Exp: 2036-04-20→ Common Stock (2,150 underlying)
Footnotes (1)
- [F1]This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on April 20, 2027.